Genervon Biopharmaceuticals LLC - Product Pipeline Review

Global Markets Direct’s, ‘Genervon Biopharmaceuticals LLC - Product Pipeline Review - 2016’, provides an overview of the Genervon Biopharmaceuticals LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Genervon Biopharmaceuticals LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Genervon Biopharmaceuticals LLC

The report provides overview of Genervon Biopharmaceuticals LLC including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Genervon Biopharmaceuticals LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Genervon Biopharmaceuticals LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Genervon Biopharmaceuticals LLC’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Genervon Biopharmaceuticals LLC

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Genervon Biopharmaceuticals LLC’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Genervon Biopharmaceuticals ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Genervon Biopharmaceuticals LLC Snapshot 6

Genervon Biopharmaceuticals LLC Overview 6

Key Facts 6

Genervon Biopharmaceuticals LLC - Research and Development Overview 7

Key Therapeutic Areas 7

Genervon Biopharmaceuticals LLC - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Genervon Biopharmaceuticals LLC - Pipeline Products Glance 11

Genervon Biopharmaceuticals LLC - Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Phase I Products/Combination Treatment Modalities 12

Genervon Biopharmaceuticals LLC - Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Genervon Biopharmaceuticals LLC - Drug Profiles 14

GM-1020 - Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

GM-6 - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

GM-603 - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

GM-605 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

GM-606 - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

GM-607 - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

GM-609 - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

GM-631 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

GM-632 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

GM-641 - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

Genervon Biopharmaceuticals LLC - Pipeline Analysis 28

Genervon Biopharmaceuticals LLC - Pipeline Products by Target 28

Genervon Biopharmaceuticals LLC - Pipeline Products by Route of Administration 29

Genervon Biopharmaceuticals LLC - Pipeline Products by Molecule Type 30

Genervon Biopharmaceuticals LLC - Pipeline Products by Mechanism of Action 31

Genervon Biopharmaceuticals LLC - Locations And Subsidiaries 32

Head Office 32

Appendix 33

Methodology 33

Coverage 33

Secondary Research 33

Primary Research 33

Expert Panel Validation 33

Contact Us 33

Disclaimer 34

List of Tables

List of Tables

Genervon Biopharmaceuticals LLC, Key Facts 6

Genervon Biopharmaceuticals LLC - Pipeline by Indication, 2016 8

Genervon Biopharmaceuticals LLC - Pipeline by Stage ...

List of Tables

Genervon Biopharmaceuticals LLC, Key Facts 6

Genervon Biopharmaceuticals LLC - Pipeline by Indication, 2016 8

Genervon Biopharmaceuticals LLC - Pipeline by Stage of Development, 2016 9

Genervon Biopharmaceuticals LLC - Monotherapy Products in Pipeline, 2016 10

Genervon Biopharmaceuticals LLC - Phase II, 2016 11

Genervon Biopharmaceuticals LLC - Phase I, 2016 12

Genervon Biopharmaceuticals LLC - Preclinical, 2016 13

Genervon Biopharmaceuticals LLC - Pipeline by Target, 2016 28

Genervon Biopharmaceuticals LLC - Pipeline by Route of Administration, 2016 29

Genervon Biopharmaceuticals LLC - Pipeline by Molecule Type, 2016 30

Genervon Biopharmaceuticals LLC - Pipeline Products by Mechanism of Action, 2016 31

List of Figures

List of Figures

Genervon Biopharmaceuticals LLC - Pipeline by Top 10 Indication, 2016 8

Genervon Biopharmaceuticals LLC - Pipeline by Stage of Development, 2016 9 ...

List of Figures

Genervon Biopharmaceuticals LLC - Pipeline by Top 10 Indication, 2016 8

Genervon Biopharmaceuticals LLC - Pipeline by Stage of Development, 2016 9

Genervon Biopharmaceuticals LLC - Monotherapy Products in Pipeline, 2016 10

Genervon Biopharmaceuticals LLC - Pipeline by Target, 2016 28

Genervon Biopharmaceuticals LLC - Pipeline by Molecule Type, 2016 30

Genervon Biopharmaceuticals LLC - Pipeline Products by Mechanism of Action, 2016 31

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports